These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 36535827)

  • 1. Association of sugammadex reversal of neuromuscular block and postoperative length of stay in the ambulatory care facility: a multicentre hospital registry study.
    Azimaraghi O; Ahrens E; Wongtangman K; Witt AS; Rupp S; Suleiman A; Tartler TM; Wachtendorf LJ; Fassbender P; Choice C; Houle TT; Eikermann M; Schaefer MS
    Br J Anaesth; 2023 Mar; 130(3):296-304. PubMed ID: 36535827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recovery characteristics of patients receiving either sugammadex or neostigmine and glycopyrrolate for reversal of neuromuscular block: a randomised controlled trial.
    Paech MJ; Kaye R; Baber C; Nathan EA
    Anaesthesia; 2018 Mar; 73(3):340-347. PubMed ID: 29214645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised controlled trial of sugammadex or neostigmine for reversal of neuromuscular block on the incidence of pulmonary complications in older adults undergoing prolonged surgery.
    Togioka BM; Yanez D; Aziz MF; Higgins JR; Tekkali P; Treggiari MM
    Br J Anaesth; 2020 May; 124(5):553-561. PubMed ID: 32139135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery of muscle function after deep neuromuscular block by means of diaphragm ultrasonography and adductor of pollicis acceleromyography with comparison of neostigmine vs. sugammadex as reversal drugs: study protocol for a randomized controlled trial.
    Cappellini I; Picciafuochi F; Ostento D; Danti G; De Gaudio AR; Adembri C
    Trials; 2018 Feb; 19(1):135. PubMed ID: 29467022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of sugammadex versus neostigmine for reversal of neuromuscular block on hospital costs of care.
    Wachtendorf LJ; Tartler TM; Ahrens E; Witt AS; Azimaraghi O; Fassbender P; Suleiman A; Linhardt FC; Blank M; Nabel SY; Chao JY; Goriacko P; Mirhaji P; Houle TT; Schaefer MS; Eikermann M
    Br J Anaesth; 2023 Feb; 130(2):133-141. PubMed ID: 36564246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials.
    Carron M; Zarantonello F; Tellaroli P; Ori C
    J Clin Anesth; 2016 Dec; 35():1-12. PubMed ID: 27871504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of residual neuromuscular block with neostigmine or sugammadex and postoperative pulmonary complications: a prospective, randomised, double-blind trial in high-risk older patients.
    Ledowski T; Szabó-Maák Z; Loh PS; Turlach BA; Yang HS; de Boer HD; Asztalos L; Shariffuddin II; Chan L; Fülesdi B
    Br J Anaesth; 2021 Aug; 127(2):316-323. PubMed ID: 34127252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of sugammadex and neostigmine for reversal of rocuronium-induced neuromuscular blockade in children.
    Ammar AS; Mahmoud KM; Kasemy ZA
    Acta Anaesthesiol Scand; 2017 Apr; 61(4):374-380. PubMed ID: 28185260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade in Patients With Severe Renal Impairment: A Randomized, Double-Blinded Study.
    Oh MW; Mohapatra SG; Pak T; Hermawan A; Chen CA; Thota B; Chen J; Siu E; Park J; Moon TS
    Anesth Analg; 2024 May; 138(5):1043-1051. PubMed ID: 38190344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of sugammadex vs. neostigmine on postoperative respiratory complications and advanced healthcare utilisation: a multicentre retrospective cohort study.
    Suleiman A; Munoz-Acuna R; Azimaraghi O; Houle TT; Chen G; Rupp S; Witt AS; Azizi BA; Ahrens E; Shay D; Wongtangman K; Wachtendorf LJ; Tartler TM; Eikermann M; Schaefer MS
    Anaesthesia; 2023 Mar; 78(3):294-302. PubMed ID: 36562202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromuscular Blockade and Reversal Practice Variability in the Outpatient Setting: Insights From US Utilization Patterns.
    Bash LD; Black W; Turzhitsky V; Urman RD
    Anesth Analg; 2021 Dec; 133(6):1437-1450. PubMed ID: 34784330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of sugammadex and neostigmine on hospital stay in robot-assisted laparoscopic prostatectomy: a retrospective study.
    Min BH; Oh TK; Song IA; Jeon YT
    BMC Anesthesiol; 2020 Jul; 20(1):178. PubMed ID: 32693776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective investigation of postoperative outcome after reversal of residual neuromuscular blockade: sugammadex, neostigmine or no reversal.
    Ledowski T; Falke L; Johnston F; Gillies E; Greenaway M; De Mel A; Tiong WS; Phillips M
    Eur J Anaesthesiol; 2014 Aug; 31(8):423-9. PubMed ID: 24296853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
    Flockton EA; Mastronardi P; Hunter JM; Gomar C; Mirakhur RK; Aguilera L; Giunta FG; Meistelman C; Prins ME
    Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sugammadex versus neostigmine for routine reversal of rocuronium block in adult patients: A cost analysis.
    Hurford WE; Welge JA; Eckman MH
    J Clin Anesth; 2020 Dec; 67():110027. PubMed ID: 32980763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between choice of reversal agent for neuromuscular block and postoperative pulmonary complications in patients at increased risk undergoing non-emergency surgery: STIL-STRONGER, a multicentre matched cohort study.
    Colquhoun DA; Vaughn MT; Bash LD; Janda A; Shah N; Ghaferi A; Sjoding M; Mentz G; Kheterpal S;
    Br J Anaesth; 2023 Jan; 130(1):e148-e159. PubMed ID: 35691703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sugammadex
    Chhabra R; Gupta R; Gupta LK
    Curr Drug Saf; 2024; 19(1):33-43. PubMed ID: 36861797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of sugammadex versus neostigmine on postoperative nausea and vomiting after general anesthesia in adult patients:a single-center retrospective study.
    Ju JW; Hwang IE; Cho HY; Yang SM; Kim WH; Lee HJ
    Sci Rep; 2023 Apr; 13(1):5422. PubMed ID: 37012336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of reversal with neostigmine of low-dose rocuronium vs. reversal with sugammadex of high-dose rocuronium for a short procedure.
    Choi ES; Oh AY; Koo BW; Hwang JW; Han JW; Seo KS; Ahn SH; Jeong WJ
    Anaesthesia; 2017 Oct; 72(10):1185-1190. PubMed ID: 28493510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SUGAMMADEX versus neostigmine after ROCURONIUM continuous infusion in patients undergoing liver transplantation.
    Deana C; Barbariol F; D'Incà S; Pompei L; Rocca GD
    BMC Anesthesiol; 2020 Mar; 20(1):70. PubMed ID: 32213163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.